OCGN 8-K 2026-11-04
Ocugen, Inc. (OCGN) 8-K dated 2026-11-04 — accession 0001104659-26-122401.
Ocugen, Inc. (OCGN) is a biotechnology company listed on NASDAQ.
OCGN: Ocugen Provides Business Update with Third Quarter
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported OCGN revenue for 2026-06-30 was $1.5M. Net income was -$24.9M. Revenue was down 2.9% from 2026-03-31 to 2026-06-30. OCGN currently screens at market cap $416.4M.
Not investment advice. The OCGN SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects,” “plans,” “intends,” “may,” “could,”
Why it matters
- expects,” “plans,” “intends,” “may,” “could,”